Ikonisys
New Haven
About Ikonisys
Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $53.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: epa:ALIKO
- Website: ikonisys.com
- Phone: 2037760795
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/ikonisys-16117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.